Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04955444 · ClinicalTrials.gov registry record · NA
Opioid Use After Thyroid and Parathyroid Surgeries
A NA study of Pain, Postoperative and Opioid Use, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04955444: Completed NA study of Pain, Postoperative and Opioid Use, sponsored by The Methodist Hospital Research Institute.
NCT04955444 is a NA study of Pain, Postoperative and Opioid Use that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 240 participants, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04955444, a NA study of Pain, Postoperative and Opioid Use, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
Unnecessary opioid prescriptions for postoperative pain can increase the risk for new, persistent opioid use and dependence. Published literature suggests that most patients undergoing thyroid or parathyroid surgery can have their pain effectively managed without opioids following hospital discharge. The purpose of this quasi-experimental, quality improvement study is to develop, implement, and measure the impact of a quality improvement bundle that consists of (1) patient education, (2) provider education, and (3) electronic health record (EHR) enhancements. The proportion of patients who receive new opioid discharge prescriptions for pain management following thyroid or parathyroid surgery at Houston Methodist Hospital for up to 6 months following bundle implementation will be compared to a historical control group.
Primary Outcome
Proportion of patients who receive new opioid discharge prescriptions at discharge following a thyroidectomy or parathyroidectomy procedure. This outcome excludes continuation of previous, chronic opioid therapy.
Conditions Studied
Interventions
- OTHER Quality improvement bundle
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT04955444 record still lists
NCT04955444 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (11% lower).
The record links to 4 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Quality improvement bundle is the first listed.
NCT04955444 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04955444 about?
NCT04955444 is a clinical study titled "Opioid Use After Thyroid and Parathyroid Surgeries". Unnecessary opioid prescriptions for postoperative pain can increase the risk for new, persistent opioid use and dependence. Published literature suggests that most patients undergoing thyroid or parathyroid surgery can have their pain effectively managed without opioids following hospital discharge...
What is the current status of trial NCT04955444?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2021-06-14. Estimated completion is 2021-12-31.
What conditions does trial NCT04955444 study?
This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Thyroidectomy, Parathyroidectomy.
What interventions are being tested in trial NCT04955444?
The interventions under investigation include: Quality improvement bundle (OTHER).
Who is sponsoring clinical trial NCT04955444?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04955444 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04955444's enrollment target sits among peer trials
240 12th of 113 higher than 101 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Dance Study for Post-surgical Pain in Breast Cancer Survivors
RECRUITING · NA
-
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
RECRUITING · NA
-
Anesthetic Optimization in Pediatric LeFort Surgeries
RECRUITING · NA
-
Latinx Children and Surgery
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
- NCT03683680 · 240 participants · NA
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI